PUBLISHER: Grand View Research | PRODUCT CODE: 1771560
PUBLISHER: Grand View Research | PRODUCT CODE: 1771560
Large Molecule Drug Discovery Outsourcing Market Summary
The global large molecule drug discovery outsourcing market size was estimated at USD 2.89 billion in 2024 and is projected to reach USD 4.83 billion by 2030, growing at a CAGR of 9.02% from 2025 to 2030. The market is driven by increased demand for biologics and next-generation therapies.
Pharmaceutical companies are increasingly shifting their focus from small molecules to larger biomolecules, including peptides, recombinant proteins, and gene-modifying agents, due to rising demand for biologics. As a result, drug sponsors are actively seeking the services of contract research organizations (CROs) that specialize in drug discovery tailored to these biologics. This trend has led to a rise in outsourcing strategies that emphasize early-phase scientific collaboration and expertise in areas such as bioassay development, structural biology, and functional screening.
Furthermore, emerging trends highlight strategic partnerships between biopharma companies and CROs that focus on innovative platform-based models, which serve to mitigate R&D risks while enhancing the progression of assets. In addition, the demand for outsourcing services is more influenced by the depth of scientific expertise, cost effectiveness, and specialization in therapeutic areas. This has led increasing demand for collaboration with partners who have a strong focus on neurodegenerative diseases, rare disorders, and autoimmune conditions.
Moreover, the global expansion of the market is transforming the landscape, as companies seek biologics innovation hubs in regions like North America and Asia Pacific. In addition, CROs are integrating AI-driven tools, biomarker discovery platforms, and automated screening processes to enhance the accuracy of candidate selection. This combination of scientific advancement, geographical growth, and digital innovation is establishing large molecule discovery outsourcing as a fundamental aspect of modern biologics R&D strategies. Such factors are expected to drive market growth over the estimated time period.
Global Large Molecule Drug Discovery Outsourcing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global large molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, end-use, and region: